Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 January 2008, Vol. 111, No. 2, pp. 741-749.
Prepublished online as a Blood First Edition Paper on October 9, 2007; DOI 10.1182/blood-2007-08-108118.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Table and Figures
Right arrow All Versions of this Article:
blood-2007-08-108118v1
111/2/741    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalez-Garcia, I.
Right arrow Articles by Brieva, J. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez-Garcia, I.
Right arrow Articles by Brieva, J. A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted August 21, 2007
Accepted October 3, 2007

Increased survival is a selective feature of human circulating antigen-induced plasma cells synthesizing high affinity antibodies

Ines Gonzalez-Garcia, Beatriz Rodriguez-Bayona, Francisco Mora-Lopez, Antonio Campos-Caro, and Jose A Brieva*

Servicio de Inmunologia and Unidad de Investigacion, Hospital Universitario Puerta del Mar, Cadiz, Spain

* Corresponding author; email: josea.brieva.sspa{at}juntadeandalucia.es.

The present study shows that tetanus toxoid (tet)-booster releases to the human circulation two subsets of specific plasma cells (PC), as defined by phenotype and morphology, which clearly differed in the staining capacity of their cytoplasmic antibodies (Ab) with FITC-labeled tet-fragment C (tetC). These cells, termed tetCHIGH and tetCINT PC according to their either high or intermediate tetC-FITC staining-capacity, exhibit similar rapid temporal kinetics in the blood (5th-8th days post-boost), contain many cycling cells, express equivalent amounts of BLIMP-1 mRNA and produce similar quantities of IgG. However, Ab synthesized by tetCHIGH PC show a tetC-affinity more than 10 times higher than that exhibited by tetCINT PC Ab, and indicated by IGVH sequence analysis. Chemotaxis to CXCL12, a requisite for BM PC homing, is similar for both cell types. Circulating non-specific and tetCINT PC, but not tetCHIGH PC, tend to undergo spontaneous apoptosis, as demonstrated by APO2.7 and activated-caspase 3 expression, and cell recovery. These results indicate that tet-booster generates two discrete subsets of specific PC exhibiting different ranges of Ab-affinity for the immunogen, and that only those synthesizing high-affinity Ab show enhanced survival. This inherent property may be essential for determining the BM fate of PC secreting high-affinity Ab.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020